Chicago, IL, March 14, 2015 --(PR.com
)-- Product development professionals throughout the medical device industry now have the opportunity to discuss the most recent challenges and best practices for effective product development operations at the Strategic Medical Device New Product Development Conference. In-depth sessions, panels, case studies, and workshops on a wide variety of topics will be presented by the most influential leaders within the medical industry, offering a unique opportunity to network and share ideas with peers.
The conference, hosted by Q1 Productions, will be held June 8-9, 2015 in Alexandria, Virginia. The biggest challenges facing new product development executives will be addressed, such as acquiring more clinical data while maintaining budgets, accelerating product development timelines, portfolio management, and more. Industry leaders who will be on hand offering insight during the course of the conference sessions include Tom Granzow of Stryker, Derrill Wolkins of Medtronic, and Tom Wilke of Covidien.
This conference will provide opportunities for small group discussion on the regulatory and reimbursement challenges faced in the product development space for more in-depth networking, as well as further examining best practices for designing product to value-bridging the gap between the desires of research and development with over business objectives. Conference delegates will also obtain an FDA perspective on increasing probability of medical device clearance from Philip Desjardins, counsel at Arnold & Porter, formerly Associate Director of Policy with CDRH/FDA.
For more information, or to register for the Strategic Medical Device New Product Development Conference, please visit www.q1productions.com/productdevelopment or email firstname.lastname@example.org. You can also follow the conference on Twitter @Q1Productions, #DEVPD15.
About the Organizer:
Q1 Productions designs and develops webinars, training courses, conference programs and forums aimed at specifically targeted audiences throughout highly regulated industries in order to provide strategic learning and timely program content. Through a highly structured production process focused on research calls with end-users and key stakeholders in the industry, our team is able to understand the immediate business concerns of today’s leading executives. Whether focusing on new or pending legislative and health policy issues or enhanced technologies or processes that will drive efficiency, our programs provide solutions to the urgent educational and information needs of our attendees.